Manchester and Israel partnership to boost stem cell and cancer researchJul. 29, 2013
A new partnership approach, which will also see combined studies into heart disease, stem cell and genetic research, was agreed by the two world-leading research Centres this week.
Professor Eliezer Shalev, Dean of The Ruth and Bruce Rappaport Faculty of Medicine at the Technion- Israel Institute of Technology visited The University of Manchester and Central Manchester University Hospitals NHS Foundation Trust to sign a Memorandum of Understanding – committing to joint-research.
The Memorandum was also signed by Professors Ian Jacobs, Dean of the Faculty of Medicine and Human Science, and Professor Martin Humphries, Dean of the Faculty of Life Sciences at The University of Manchester to strengthen collaboration.
Professor Shalev, Dean of The Ruth and Bruce Rappaport Faculty of Medicine at the Technion- Israel Institute of Technology, said: “This is an exciting opportunity for The Technion to strengthen our links with The University of Manchester. I have been impressed with the close working relationship between the University and hospitals. Our researchers in Israel will benefit greatly from working closely with our friends in Manchester to deliver world-class medical research.”
For the full press release on The University of Manchester website click here.